GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors.

Abstract

Neuropeptide FF (NPFF) interacts with specific receptors to modulate opioid functions in the central nervous system. On dissociated neurons and neuroblastoma cells (SH-SY5Y) transfected with NPFF receptors, NPFF acts as a functional antagonist of μ-opioid (MOP) receptors by attenuating the opioid-induced inhibition of calcium conductance. In the SH-SY5Y model, MOP and NPFF(2) receptors have been shown to heteromerize. To understand the molecular mechanism involved in the anti-opioid activity of NPFF, we have investigated the phosphorylation status of the MOP receptor using phospho-specific antibody and mass spectrometry. Similarly to direct opioid receptor stimulation, activation of the NPFF(2) receptor by [D-Tyr-1-(NMe)Phe-3]NPFF (1DMe), an analog of NPFF, induced the phosphorylation of Ser-377 of the human MOP receptor. This heterologous phosphorylation was unaffected by inhibition of second messenger-dependent kinases and, contrarily to homologous phosphorylation, was prevented by inactivation of G(i/o) proteins by pertussis toxin. Using siRNA knockdown we could demonstrate that 1DMe-induced Ser-377 cross-phosphorylation and MOP receptor loss of function were mediated by the G protein receptor kinase GRK2. In addition, mass spectrometric analysis revealed that the phosphorylation pattern of MOP receptors was qualitatively similar after treatment with the MOP agonist Tyr-D-Ala-Gly (NMe)-Phe-Gly-ol (DAMGO) or after treatment with the NPFF agonist 1DMe, but the level of multiple phosphorylation was more intense after DAMGO. Finally, NPFF(2) receptor activation was sufficient to recruit β-arrestin2 to the MOP receptor but not to induce its internalization. These data show that NPFF-induced heterologous desensitization of MOP receptor signaling is mediated by GRK2 and could involve transphosphorylation within the heteromeric receptor complex.

• Authors: Lionel Moulédous, Carine Froment, Stéphanie Dauvillier, Odile Burlet-Schiltz, Jean-Marie Zajac, Catherine Mollereau
• Journal: The Journal of biological chemistry (J Biol Chem) Vol. 287 Issue 16 Pg. 12736-49 (Apr 13 2012) ISSN: 1083-351X [Electronic] United States
• PMID: 22375000 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Analgesics, Opioid
• Arrestins
• Receptors, G-Protein-Coupled
• Receptors, Neuropeptide
• Receptors, Opioid, mu
• beta-Arrestins
• neuropeptide FF receptor
• seven-transmembrane G-protein-coupled receptor
• Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
• Serine
• GRK2 protein, human
• G-Protein-Coupled Receptor Kinase 2
• Heterotrimeric GTP-Binding Proteins

Topics

• Amino Acid Sequence
• Analgesics, Opioid (pharmacology)
• Arrestins (metabolism)
• Cell Line, Tumor
• Enkephalin, Ala(2)-MePhe(4)-Gly(5)- (pharmacology)
• G-Protein-Coupled Receptor Kinase 2 (genetics, metabolism)
• Gene Knockdown Techniques
• Heterotrimeric GTP-Binding Proteins (metabolism)
• Humans
• Molecular Sequence Data
• Neuroblastoma
• Phosphorylation (physiology)
• Receptors, G-Protein-Coupled (metabolism)
• Receptors, Neuropeptide (metabolism)
• Receptors, Opioid, mu (agonists, metabolism)
• Second Messenger Systems (drug effects, physiology)
• Serine (metabolism)
• Signal Transduction (drug effects, physiology)
• beta-Arrestins